John Lusaitis, MS



Hearing and Speech Therapy   -  Pennsylvania,  Landisville

 Overview

John Lusaitis, MS works in Landisville, Pennsylvania is a specialist in Hearing and Speech Therapy. 

 Specialties

  • Hearing and Speech Therapy

 State License

  • Pennsylvania

 Education & Training

Education for John Lusaitis, MS are not present.

 Awards

Awards for John Lusaitis, MS are not present.

 Dr. Lusaitis Reviews

Reviews for John Lusaitis, MS are not present. Be the first to review this doctor!
 Add Review as registered PatientOR Add Review as Guest

 Office Locations


Primary location

 Office Address
875 Church Street
Pennsylvania (PA)
Landisville
17538
 Phone:(717) 898-3899

Accepting New Patients

  • No
* Please verify this information when scheduling an appointment.

 Map & Directions



Office Address, 875 Church Street, Landisville, Pennsylvania (PA), 17538




 Insurances Accepted (check insurance plans)

  • Choice Plus POS
  • Coventry Health America PPO
  • Coventry Health Care
  • First Health (Coventry Health Care)
  • First Health (Coventry Health Care) PPO
  • Navigate HMO
  • Navigate POS
  • Options PPO
  • UnitedHealthCare

* Please verify this information when scheduling an appointment.

 Blog Posts

Blog Posts for John Lusaitis, MS are not present.

 Patients Questions

Patients questions for John Lusaitis, MS are not present.

 Affiliated Hospitals

Affiliated hospitals for John Lusaitis, MS are not present.
  •  Latest reviews for Hearing and Speech Therapy specialists

  • Dr. C. is a pleasant, professional caring and fun doctor. Answered all my questions on a keep it simple level and explained everything. He took his time. I will refer them when needed. What a great group!
    07 February 2024
    (6)
  • He is the best if you need help with panic attacks. He fixed up my medication and I feel better.
    31 January 2024
    (40)
  • Dr. Jungblut and staff are all professional, fun, conscientious. Been going here for a long time. My children and grandchildren now see Dr. Jungblut too.
    24 January 2024
    (7)
Close
Sign Up / Login
Connect with Sign Up / Login